DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency

Understanding which driver mutations are required for cancer initiation, maintenance, or both phases remains poorly understood. In this study, we uncover that highly prevalent preleukemic DNMT3A mutations are only required during disease initiation but become dispensable after leukemic transformation, uncovering the context-specific role of this driver mutation with important therapeutic implications. See related commentary by Zhou and Huang, p. 428.

Authors

Institutions

Publication Details

Journal
Cancer Discovery
Published
2025-11-20
DOI
https://doi.org/10.1158/2159-8290.cd-24-1604
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency

Cailin Collins, Kyle M. Loh, Kensuke Kayamori, Jonas L. Fowler et al.
Cancer Discovery
Acute Myeloid Leukemia Research
article

DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency

Cailin Collins, Kyle M. Loh, Kensuke Kayamori, Jonas L. Fowler, Daiki Karigane, Eleanor Hilgart, Amy C. Fan, Hiromitsu Nakauchi, Yang Feng, Fabian P. Suchy, Michael A. Koldobskiy, Thomas Köhnke, Andrew P. Feinberg, Ravindra Majeti, Yusuke Nakauchi, Athreya Rangavajhula, Masashi Miyauchi, Eduardo Martinez-Montes
article en

Abstract

Understanding which driver mutations are required for cancer initiation, maintenance, or both phases remains poorly understood. In this study, we uncover that highly prevalent preleukemic DNMT3A mutations are only required during disease initiation but become dispensable after leukemic transformation, uncovering the context-specific role of this driver mutation with important therapeutic implications. See related commentary by Zhou and Huang, p. 428.

Cancer DiscoveryVol. 16(3)
Johns Hopkins University (US), Bunkyo University (JP), Palo Alto University (US), California Institute for Regenerative Medicine (US), Johns Hopkins Medicine (US), Institute for Stem Cell Biology and Regenerative Medicine (IN), The University of Tokyo (JP), Stanford University (US)
Openalex Percentile: Top 54%
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.